Half-year report · HY
7747.TEDINET S100XKTG
Period2025-07-01 → 2025-12-31
Filed2026-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥71.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥120.0bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥61.5bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥24.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥17.4bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥24.1bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥29.6bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.8bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥24.8bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥16.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥17.2bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.7bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥17.3bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥12.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥195.9bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥193.2bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥190.1bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥37.2bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥41.8bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥158.7bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥151.4bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥158.9bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥53.5bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥54.2bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥53.5bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.2bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥37.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.7bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥17.8bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥40.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥18.3bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥957m | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.4bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥18.6bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥8.1bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.9bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥64.56 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.92 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.14 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 80.6% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.9% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.2% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥8.3bn |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥4.0bn |
| Devicereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥16.9bn |
| Devicereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥8.6bn |
| Devicereportable segment | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Devicereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥4.4bn |
| Medicalreportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥62.7bn |
| Medicalreportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥23.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-07-01 → 2025-12-31 | ¥79.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-07-01 → 2025-12-31 | ¥71.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-07-01 → 2025-12-31 | ¥28.3bn |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥7.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥3.6bn |
| Devicereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥13.0bn |
| Devicereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥5.7bn |
| Devicereportable segment | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Devicereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.5bn |
| Medicalreportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥55.8bn |
| Medicalreportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-07-01 → 2024-12-31 | ¥68.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-07-01 → 2024-12-31 | ¥61.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-07-01 → 2024-12-31 | ¥21.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 481
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 2000000000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | － | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -4622000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -1193000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -5533000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -6534000000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -0 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -10553000000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -206000000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -305000000 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -8869000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -18586000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1InterimDuration | -495000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | InterimDuration | 1607000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 1906000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -152000000 | JPY |
| Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cce | Prior1InterimDuration | － | JPY |
| Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cce | InterimDuration | 452000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 35658000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 53200000000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 37564000000 | JPY |
| Cash and cash equivalents | InterimInstant | 53500000000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -739000000 | JPY |
| Allowance for doubtful accounts ioa by group | InterimInstant | -903000000 | JPY |
| Payrolls and bonuses sga | Prior1InterimDuration | 5817000000 | JPY |
| Payrolls and bonuses sga | InterimDuration | 6682000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 964000000 | JPY |
| Provision for bonuses sga | InterimDuration | 1000000000 | JPY |
| Research and development expenses sga | Prior1InterimDuration | 5820000000 | JPY |
| Research and development expenses sga | InterimDuration | 6111000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02349-000MedicalReportableSegmentsMember | 55763000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E02349-000DeviceReportableSegmentsMember | 5727000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 61491000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 61491000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02349-000MedicalReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E02349-000DeviceReportableSegmentsMember | 7288000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 7288000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | -7288000000 | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02349-000MedicalReportableSegmentsMember | 55763000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E02349-000DeviceReportableSegmentsMember | 13016000000 | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 68780000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | -7288000000 | JPY |
| Net sales | Prior1InterimDuration | 61491000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02349-000MedicalReportableSegmentsMember | 18518000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E02349-000DeviceReportableSegmentsMember | 2457000000 | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 20976000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -3581000000 | JPY |
| Operating income | Prior1InterimDuration | 17395000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |